MedPath

Effect of PRP on male pattern hair loss

Not Applicable
Conditions
Male androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT2016021526563N1
Lead Sponsor
Vice chancellor for research of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
20
Inclusion Criteria

patients include males with male pattern androgenetic alopecia who had acquiescence for participation in this study and their baldness is grade 3v to 5 according to Hamilton-Norwood scaling system. Exclusion criteria: using minoxidil or finasteride in the last 6 months; using any other systemic or topical supplementary drugs for hair growth stimulation in the last 6 months; using drugs that can induce hair loss (eg. Retinoids, heavy metals, antithyroids, anticonvulsants, betablockers and …); specific diseases like thyroid disease, collagen vascular disease …; positive history for any kind of cancer or skin cancer and chemotherapy; any other kind of alopecia ( scaring alopecia, alopecia areata, …); steroid therapy; coagulation disorders, acquisition of aspirin, ticlopidine or other anticoagulative drugs; dialysis patients and platelet disorders (thrombocytopenia); smoker and alcoholic persons and malnutrition; and anytime patient wants to leave the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair loss improvement and stimulation of hair growth. Timepoint: Measurement on weeks 0, 4, 8, 12 and 3 months after last injection. Method of measurement: Average hair diameter and hair count in unit surface.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: At the end of treatment (3 months after last injection). Method of measurement: Effectiveness and side effects include local and systemic reactions according to patients and investigator observations.
© Copyright 2025. All Rights Reserved by MedPath